

Fundamental dimension Equity attribute | GFRLeader $6.98▲+4.65% Cap $505.3MP/E -18.1x QuantScore63/100 | BRYPeer $3.260.00% Cap $253.0MP/E 36.2x QuantScore42/100 | FETPeer $87.17▲+6.88% Cap $985.4MP/E -621.7x QuantScore49/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
93/100 |
44/100 |
94/100 |
Valuation Multiples, PEG & DCF upside | 71/100 | 87/100 | 65/100 |
Health Piotroski, Altman Z, leverage & liquidity | 39/100 | 21/100 | 43/100 |
Growth Revenue / earnings growth & margins | 10/100 | 5/100 | 35/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 50/100 | 9/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -18.1x | 36.2x | -621.7x |
Forward P/E (next FY) | 29.1x | 32.6x | 21.7x |
EV / EBITDA (TTM) | 12.9x | 5.5x | 17.0x |
Price / Sales | 1.2x | 0.8x | 1.2x |
Price / Free Cash Flow | -11.8x | -16.4x | 18.5x |
PEG ratio | 0.15 | 0.02 | -1.54 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 4 / 9 | 6 / 9 |
Altman Z-Score | 3.67 (Safe) | 0.47 (Distress) | 1.30 (Distress) |
Total debt / equity | 0.03 | 0.63 | 0.79 |
Quick ratio | 0.8x | 0.7x | 1.1x |
Interest coverage | 3.7x | 0.2x | 1.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -23.7% | -9.2% | -3.1% |
Net income growth YoY | -60.9% | -48.5% | +92.9% |
Gross margin (TTM) | 44.3% | 26.6% | 28.0% |
Operating margin (FY) | 9.8% | 19.5% | 2.4% |
FCF margin (FY) | 4.0% | 13.6% | 8.1% |
5. Trailing price performancePrice change over period |
1M return | +12.9% | 0.0% | +4.2% |
3M return | +7.2% | -3.8% | +50.7% |
6M return | +14.4% | +8.7% | +40.8% |
Year to date | +46.6% | 0.0% | +135.9% |
1Y return | +41.0% | -28.5% | +181.9% |
3Y return | +13.9% | -64.6% | +293.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $30.50 +337.0% upside | $4.64 +42.5% upside | $140.89 +61.6% upside |
Wall Street consensus target | — — | $7.00 +114.7% · range $7.00–$7.00 | — — |
Consensus stance | 100% Buy0% Hold0% Sell | 25% Buy67% Hold8% Sell | 35% Buy55% Hold10% Sell |